Buscar
Mostrando ítems 11-20 de 83
Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort
(Sage, 2020)
Objectives This study aimed to compare the clinical features, damage accrual, and survival of patients with familial and sporadic systemic lupus erythematosus (SLE). Methods A multi-ethnic, multinational Latin American SLE ...
Increased expression of c-rel, from the NF-κB/Rel family, in T cells from patients with systemic lupus erythematosus
(AAAS, 2000)
OBJECTIVE:
To explore the role of the NF
-
kappaB/Rel transcription factor family in autoimmunity,
we investigated whet
her peripheral blood mononuclear cells (PBMC) and T cells
from the blood of patients ...
Uso de rituximab (anticuerpo monoclonal anti-CD20) en lupus eritematoso sistémico refractario a tratamiento: Caso clínico
(Sociedad Médica de Santiago, 2005)
New therapeutic approaches that include depletion of B cells using
rituximab, a chimeric monoclonal antibody directed against the B cell specific antigen CD-20
have been developed for the treatment of systemic lupus ...
Síndrome de Devic asociado con lupus eritematoso sistémico. Descripción de un caso.
(2012-12-12)
El síndrome de Devic es una las enfermedades desmielinizantes del sistema nervioso central, de etiología desconocida. Se
relaciona mucho con el lupus eritematoso sistémico siendo una complicación rara y grave. Este síndrome ...
Calidad de vida de pacientes pediátricos con lupus eritematoso sistémico: Hospital de la Misericordia, Bogotá segundo semestre del 2006
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2008-03-01)
Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL)
(Sage Publications, 2017)
Objectives The objectives of this study were to examine the demographic and clinical features associated with the occurrence of pleuropulmonary manifestations, the predictive factors of their occurrence and their impact ...
Identification of Subsets of Systemic Lupus Erythematosus Patients By Principal Component Analysis and Urine Biomarkers
(American College of RheumatologyGrupo de Reumatología Universidad de Antioquia -GRUA-Malden, Estados Unidos, 2022)
Protein Kinase Inhibitors in Rheumatology
(BioMed CentralGrupo de Reumatología Universidad de Antioquia -GRUA-Londres, Inglaterra, 2023)